Skip to main content
Gencurix Inc. logo

Gencurix Inc. — Investor Relations & Filings

Ticker · 229000 ISIN · KR7229000005 KO Manufacturing
Open in API
Filings indexed 405 across all filing types
Latest filing 2024-03-28 Declaration of Voting R…
Country KR South Korea
Listing KO 229000

About Gencurix Inc.

https://www.gencurix.com/eng/

Gencurix Inc. is a molecular diagnostics company that develops and commercializes diagnostic solutions for precision medicine. The company's portfolio focuses primarily on oncology, offering prognostic, companion, and early detection tests. Key products include GenesWell BCT, a multigene prognostic test for early-stage breast cancer, and the GenesWell ddEGFR Mutation Test, a ddPCR-based companion diagnostic. Gencurix also utilizes its Droplex liquid biopsy platform for early cancer detection and develops diagnostic tests for infectious diseases. The company's core technologies include digital droplet PCR (ddPCR), real-time PCR, and liquid biopsy for analyzing circulating tumor cells (CTCs) and cell-free DNA (cfDNA).

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Regular General Meeting of Shareholders Results) and provides a detailed breakdown of the voting outcomes for various agenda items (financial statement approval, board remuneration, etc.) held on 2024-03-28. This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2024-03-28 Korean
사업보고서 (2023.12)
Audit Report / Information Classification · 100% confidence The document is a comprehensive 'Audit Report' (감사보고서) for the company 'Gencurix' (주식회사 젠큐릭스) for the fiscal year ending December 31, 2023. It includes the independent auditor's report, financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes to the financial statements. This is a full financial audit report, not an earnings release or a summary, and it is not an annual report (10-K) in the sense of a full regulatory filing containing management discussion and analysis (MD&A) and business descriptions, but rather the standalone audit report package. Therefore, it is classified as an Audit Report. FY 2023
2024-03-20 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from a Korean company (Gencurix) titled 'Audit Report Submission' (감사보고서 제출). It provides a summary of financial data, audit opinions, and key financial metrics (assets, liabilities, profit/loss) for the current and previous fiscal years. While it contains financial data, it is a standard regulatory disclosure announcement (DART filing) summarizing the audit results rather than the full, multi-page annual report document itself. Therefore, it is classified as a Regulatory Filing (RNS). FY 2023
2024-03-18 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Gencurix. It outlines the date, location, and agenda items (such as approval of financial statements, amendments to articles of incorporation, and director compensation). This type of document is a standard proxy solicitation or notice of meeting material provided to shareholders to inform them of upcoming voting items, which falls under the Proxy Solicitation & Information Statement category.
2024-03-12 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a formal 'Notice of Annual General Meeting' (주주총회소집공고) for Gencurix, detailing the meeting date, agenda items (financial statement approval, board changes, etc.), and providing management information and financial summaries. This is a standard proxy solicitation document sent to shareholders to inform them of the upcoming meeting and request their participation/votes. In the context of the provided categories, this fits the 'Proxy Solicitation & Information Statement' (PSI) classification.
2024-03-12 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea (often associated with the DART system) used to solicit shareholder votes for an upcoming Annual General Meeting (AGM). It contains information about the meeting date, agenda items, and proxy solicitation details. While it includes some financial data, it is primarily a proxy solicitation document rather than an Annual Report or an Earnings Release. Therefore, it is classified as a Proxy Solicitation & Information Statement.
2024-03-12 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.